Search research articles
Contact Us
Filters
Showing results (171-180 of 182) with videos related to
Page
of 19
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 29, 2023
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study
Serena Ruggieri, Luca Prosperini, Sarmad Al-Araji, et al.
Therapeutic Advances in Neurological Disorders
|
December 31, 2025
Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian study
Matteo Lucchini, Giovanna Borriello, Shalom Haggiag, et al.
Neurology
|
November 23, 2021
Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies
Carla Tortorella, Alessandra Aiello, Claudio Gasperini, et al.
Journal of Neurology
|
November 14, 2019
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study
Luca Prosperini, Antonio Cortese, Matteo Lucchini, et al.
Vaccines
|
July 27, 2024
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study
Alessandra Vergori, Giulia Matusali, Eleonora Cimini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 19, 2021
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis
Massimiliano Di Filippo, Cinzia Cordioli, Simona Malucchi, et al.
Brain : a Journal of Neurology
|
September 13, 2015
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis
Pietro Iaffaldano, Giuseppe Lucisano, Carlo Pozzilli, et al.
Neurology
|
November 3, 2017
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study
Alice Laroni, Alessio Signori, Giorgia T Maniscalco, et al.
European Journal of Neurology
|
December 11, 2020
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study
Maria Di Gregorio, Valentina Liliana Adriana Torri Clerici, Giuseppe Fenu, et al.
Journal of Neurology
|
February 22, 2021
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study
Sebastiano Bucello, Pietro Annovazzi, Paolo Ragonese, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 182) with videos related to
Sort By:
Page
of 19
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 29, 2023
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study
Serena Ruggieri, Luca Prosperini, Sarmad Al-Araji, et al.
Therapeutic Advances in Neurological Disorders
|
December 31, 2025
Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian study
Matteo Lucchini, Giovanna Borriello, Shalom Haggiag, et al.
Neurology
|
November 23, 2021
Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies
Carla Tortorella, Alessandra Aiello, Claudio Gasperini, et al.
Journal of Neurology
|
November 14, 2019
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study
Luca Prosperini, Antonio Cortese, Matteo Lucchini, et al.
Vaccines
|
July 27, 2024
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study
Alessandra Vergori, Giulia Matusali, Eleonora Cimini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 19, 2021
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis
Massimiliano Di Filippo, Cinzia Cordioli, Simona Malucchi, et al.
Brain : a Journal of Neurology
|
September 13, 2015
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis
Pietro Iaffaldano, Giuseppe Lucisano, Carlo Pozzilli, et al.
Neurology
|
November 3, 2017
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study
Alice Laroni, Alessio Signori, Giorgia T Maniscalco, et al.
European Journal of Neurology
|
December 11, 2020
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study
Maria Di Gregorio, Valentina Liliana Adriana Torri Clerici, Giuseppe Fenu, et al.
Journal of Neurology
|
February 22, 2021
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study
Sebastiano Bucello, Pietro Annovazzi, Paolo Ragonese, et al.
Page
of 19